Mapping Special Interest Group Conference call 4 November 2013 20:00 UTC https://www1.gotomeeting.com/join/834437049 Meeting ID: 834-437-049 Audio will.

Slides:

Advertisements

Similar presentations

September, 2005What IHE Delivers 1 CDA-based content integration profiles Philippe Lagouarde, Cegedim Co-chair Vendor, IHE-France.

Advertisements

1 Sep 15Fall 05 Standards in Medical Informatics Standards Nomenclature Terminologies Vocabularies.

C-CDA Constraints FACA - Strategy Discussion June 23, 2014 Mark Roche, MD.

Update on Vocabularies and Value Sets for Meaningful Use Betsy Humphreys, MLS, FACMI Deputy Director National Library of Medicine National Institutes of.

Companion Guide to HL7 Consolidated CDA for Meaningful Use Stage 2

NLM Vocabulary Update Betsy Humphreys Deputy Director, NLM.

The Final Standards Rule John D. Halamka MD. Categories of Standards Content Vocabulary Privacy/Security.

Public Health Reporting Initiative June 13, 2012.

Public Health Reporting Initiative October 3, 2012.

Medication Allergies Grace Shelby Sara Bradley. Description A group of symptoms caused by an allergic reaction to a medication.

Betsy L. Humphreys, MLS National Library of Medicine National Institutes of Health U.S. Department of Health and Human Services Standards (including Vocabulary):

Public Health Reporting Initiative Stage 3 Sprint: Implementation Guide Development Phone: x

Page 0 10/19/2015 Welcome to the VMCoP Meeting July 21st, 2009.

HIT Standards Committee Clinical Operations Workgroup Update on Vocabulary Task Force Jamie Ferguson Kaiser Permanente Betsy Humphreys National Library.

HIT Standards Committee Clinical Operations Workgroup Report Jamie Ferguson, Chair Kaiser Permanente John Halamka, Co-chair Harvard Medical School 20 August,

HIT Policy Committee Clinical Operations Workgroup Report Jamie Ferguson Kaiser Permanente John Halamka Harvard Medical School 16 July, 2009.

Public Health Reporting Initiative Stage 3 Sprint: Implementation Guide Development Phone: x

Query Health Vendor Advisory Meeting 12/15/2011. Agenda Provide Overview of Query Health Seek Guidance and Feedback on Integration Approaches.

INFORMATION DEPLOYED. SOLUTIONS ADVANCED. MISSIONS ACCOMPLISHED. Chemotherapy Order Management System (COMS) Stage 2 Enhancement Sprint Demonstration 3/28/2014.

Public Health Reporting Initiative Stage 3 Sprint: Implementation Guide Development 1.

This material was developed by Duke University, funded by the Department of Health and Human Services, Office of the National Coordinator for Health Information.

INFORMATION DEPLOYED. SOLUTIONS ADVANCED. MISSIONS ACCOMPLISHED. Chemotherapy Order Management System (COMS) Stage 2 Enhancement Sprint Demonstration 8/22/2014.

Introduction to HL7 Version 3 W. Ed Hammond February 25, 2008.

INFORMATION DEPLOYED. SOLUTIONS ADVANCED. MISSIONS ACCOMPLISHED. Chemotherapy Order Management System (COMS) Stage 2 Enhancement Sprint Demonstration 5/30/2014.

HIT Standards Committee Clinical Operations Workgroup, Vocabulary Task Force Update on Vocabulary For Stage 2 Jamie Ferguson, Kaiser Permanente Betsy Humphreys,

HIT Standards Committee Clinical Operations Workgroup Jamie Ferguson Kaiser Permanente John Halamka Harvard University February 24, 2010.

HIT Standards Committee Clinical Operations Workgroup Report on Gaps and Next Steps Jamie Ferguson Kaiser Permanente John Halamka Harvard Medical School.

Page 0 2/16/2016 May 19th, 2009 Welcome to the VMCoP Meeting.

Proposed S&I Public Health Reporting Initiative 1 Challenge -There is a lack of harmonized activities to enable electronic data exchange between clinical.

Data Gathering HITPC Workplan HITPC Request for Comments HITSC Committee Recommendations gathered by ONC HITSC Workgroup Chairs ONC Meaningful Use Stage.

SNOMED CT Vendor Introduction 27 th October :30 (CET) Implementation Special Interest Group Tom Seabury IHTSDO.

Mapping Interest Group Conference call 24 Jan :00 to 21:00 UTC password: “MapSIG”

ITI Infrastructure - Wednesday November 7th, IHE IT infrastructure “Terminology Sharing” Christel Daniel (AP-HP, INSERM, Paris), Ana Esterlich (GIP-DMP),

Mapping Special Interest Group Conference call 10 June :00 UTC Meeting ID: Use IHTSDO conference.

Mapping Special Interest Group Conference call Monday, 9 December :00-21:00 UTC Meeting ID:

Mapping Special Interest Group Conference call Monday, 13 January :00-21:00 UTC Meeting ID:

Mapping Special Interest Group Conference call Monday, 8 September :00 UTC

Mapping SIG Conference call June 20, :00 UTC password: “MapSIG” Meeting ID: Use.

Implementation Workgroup Udayan Mandavia, iPatientCare, Inc. With: Kedar Mehta and Arnaz Bharucha July 28, 2014 Constraining the CCDA User Experience Presentation.

Canadian SNOMED CT® Extensions Challenges & Lessons learned Presentation to Implementation SIG October 2012 Presented by Linda Parisien and Beverly Knight.

Dispelling the myths about dm+d Presenter: Karen ReesDate: 10 th December 2014 dm+d and the NHS Standard.

Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting July 18, 2011.

1 The information contained in this presentation is based on proposed and working documents. Health Information Exchange Interoperability Minnesota Department.

Mapping SIG Conference call March 21, :00 UTC password: “MapSIG” Meeting ID: Use IHTSDO conference.

Map Special Interest Group Conference call April 15, :00 UTC Meeting ID: Use IHTSDO conference.

Mapping Special Interest Group Sheraton Crystal City Ballroom B 7 October :00-12:30 EDT 13:30-15:00 EDT.

Public Health - Clinical LOINC Meeting Sundak Ganesan, M.D. Health Scientist, Surveillance Operations Team National Notifiable Disease Surveillance (NNDSS)

Mapping SIG Face-to-Face Meeting Venue: Amba Charing Cross Hotel

Mapping Special Interest Group

Representation of Hypersensitivity, Allergy and adverse reactions in SNOMED CT Bruce Goldberg, MD, PhD.

Procedure Note (V3) ** = Required sections

Networking and Health Information Exchange

Mapping Special Interest Group

CCHIT Roadmap Discussion Items

Code4health – Interoperability Developers

Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Respiratory.

Mapping Interest Group

Mapping SIG Conference call June 6, :00 UTC

Allergy discussion I want to throw something else into the mix - recording of allergies using 'Allergy to X' as a concept from the Clinical Findings hierarchy.

Mapping SIG face-to-face meeting October 24, 2016 The Museum of New Zealand Te Papa Tongarewa

Patient Care WG Allergies and Intolerances June 25, SDWG

Health Information Exchange Interoperability

Condition Resource - Overview

Electronic Health Record Access Control 7

Patient Care WG Allergy and Intolerances Project

Washington State Employment Security Department

Daniel A. Pollock, M.D. & Robert H. Dolin, M.D.

Patient Care WG Allergy and Intolerances Project

Evidence of Infection (Dialysis) Reporting in CDA and greenCDA:

Presentation transcript:

Mapping Special Interest Group Conference call 4 November :00 UTC Meeting ID: Audio will be provided with GoToMeeting

MapSIG Agenda Minutes of face-to-face meeting – JRCMinutes of face-to-face meeting – JRC Technical committee report; RF2 map standard – JRCTechnical committee report; RF2 map standard – JRC Mapping to ICF - JMillarMapping to ICF - JMillar Workplan review and discussion:Workplan review and discussion: Implementation SIG: “Mapping to SNOMED CT”Implementation SIG: “Mapping to SNOMED CT” Implementation SIG report –JKolaImplementation SIG report –JKola Comments from vendor community - CHallComments from vendor community - CHall Map Education guidelines – KG, RSMap Education guidelines – KG, RS Report from Mapping Service Team – KG, DMReport from Mapping Service Team – KG, DM Report on extension maps - GroupReport on extension maps - Group Next call 12/9/ UTC?Next call 12/9/ UTC?

MapSIG Upcoming Meetings MapSIG Call December 9 th 2000UTC? (remember daylight time)MapSIG Call December 9 th 2000UTC? (remember daylight time) AMIA November th Washington DCAMIA November th Washington DC

MapSIG Allergy List: CDA R2 “Allergy to penicillin with hives” Allergies and Adverse Reactions - Penicillin - Hives Aspirin - Wheezing Codeine - Itching and nausea - - -

MapSIG SNOMED CT v |Allergy to penicillin(finding)| IS_A=Propensity to adverse reactions(disorder)IS_A=Propensity to adverse reactions(disorder) Causative agent=? |Penicllin- class of antibiotic(substance)|Causative agent=? |Penicllin- class of antibiotic(substance)| Has definitional manifestation= |Allergic reaction to drug(disorder)|Has definitional manifestation= |Allergic reaction to drug(disorder)| User guide permits: |Penicillin – class of antibiotic(substance)| |Penicillin –class of antibiotic(pharmaceutical/biological product)|

MapSIG Ambulatory Setting Test Data 2014 Stage 2 NIST criteria(proposed) TD a.7 – 1: Electronically Record Active Medication Allergies “Allergy to sulfamethoxazole with wheezing” “Allergy to sulfamethoxazole with wheezing” Allergy: Sulfamethoxazole [RxNorm: 10180]Allergy: Sulfamethoxazole [RxNorm: 10180] Reaction: WheezingReaction: Wheezing Status: Vendor-supplied (e.g. Active)Status: Vendor-supplied (e.g. Active)

MapSIG CDA2 IHE Consolidation

MapSIG CDA2 IHE Consolidation “Allergy to codeine 30mg/ml” <value xsi:type="CD" code=" " displayName="Propensity to adverse reactions to drug" codeSystem=" " codeSystemName="SNOMED CT"> <code code="763049" displayName="Codeine 30mg/ml" codeSystem=" " codeSystemName="RxNorm">

MapSIG CDA2 IHE Consolidation “Allergy to codeine with nausea” <value xsi:type="CD" code=" " codeSystem=" " codesystemName=SNOMED CT displayName="Nausea"/>....

MapSIG CDA2 IHE Consolidation “Allergy to codeine with severe nausea” <value xsi:type="CD" code=" " codeSystem=" " codesystemName=SNOMED CT displayName="Nausea"/>....

MapSIG US Realm MU Stage 2 “Allergy to penicillin with severe hives” IS_A=Propensity to adverse reactions(disorder)IS_A=Propensity to adverse reactions(disorder) Causative agent=RxNORM7689|Penicillins|Causative agent=RxNORM7689|Penicillins| Has manifestation= |Weal(disorder)|Has manifestation= |Weal(disorder)| Severity= |Severe(qualifier)|Severity= |Severe(qualifier)|